Pharmacokinetic-Pharmacodynamic Relationships for Opioids in Balanced Anaesthesia
- 1 October 1995
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 29 (4) , 231-242
- https://doi.org/10.2165/00003088-199529040-00003
Abstract
The pure μ-receptor opioid agonists fentanyl, sufentanil and alfentanil are commonly used to provide the specific anti-nociceptive component of a balanced anaesthesia technique. Trefentanil and remifentanil are new opioids with a very short duration of action. Remifentanil has an ester structure and is very rapidly metabolised by blood and tissue esterases. Different perioperative stimuli require different plasma concentrations to suppress responses of the patient. The ability of the anaesthesiologist to select a precise dosage scheme for the individual patient is impeded by the large inter-individual pharmacokinetic and pharmacodynamic variability. In addition, the combination of opioids and other drugs used to produce the desired components of balanced anaesthesia may exert additive, synergistic or antagonistic effects. Knowledge of factors influencing the pharmacokinetic s and pharmacodynamics is still fragmentary and often controversial. Consequently, the opioid dose needs to be adjusted according to the responses of the patient during surgery to ensure adequate anaesthesia and rapid recovery. The duration of action is not predicted by the elimination half-life alone. The decline in effect-site concentration is dependent on the complex entity of infusion duration, and pharmacokinetic and pharmacodynamic parameters. Computer simulations of infusions of varying duration have been extremely useful when selecting an opioid for a specific clinical scenario on a rational basis. Traditionally, opioids are still administered by intermittent bolus injections. A disadvantage of this method of administration is that plasma concentrations fluctuate above and below the level required for adequate anaesthesia. Computer-assisted infusion pumps make it possible to target a particular drug concentration in plasma and to maintain or change this concentration as needed. This technique provides more stable anaesthesia and a more rapid recovery of the patient.Keywords
This publication has 64 references indexed in Scilit:
- Pharmacokinetic Parameters Relevant to Recovery from OpioidsAnesthesiology, 1994
- Triple Anesthetic CombinationAnesthesia & Analgesia, 1994
- Fentanyl or Alfentanil Decreases the Minimum Alveolar Anesthetic Concentration of Isoflurane in Surgical PatientsAnesthesia & Analgesia, 1994
- Potentiation of acute opioid-induced respiratory depression and reversal of tolerance by the calcium antagonist nimodipine in awake ratsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1993
- Vomiting After Alfentanil AnesthesiaAnesthesia & Analgesia, 1992
- Fentanyl and Sufentanil Increase Intracranial Pressure in Head Trauma PatientsAnesthesiology, 1992
- Pharmacokinetics of Sufentanil in Obese PatientsAnesthesia & Analgesia, 1991
- Sufentanil Pharmacokinetics in Patients with CirrhosisAnesthesia & Analgesia, 1989
- EEG Quantitation of Narcotic EffectAnesthesiology, 1985
- The Pharmacokinetics of Sufentanil in Surgical PatientsAnesthesiology, 1984